A case of nonislet cell tumor hypoglycemia associated with malignant mesothelioma requiring a multifaceted approach for optimal glycemic control. Issue 10 (28th October 2021)

• Record Type: Journal Article
• Authors: Ono, Mariko; Maeda, Yuki; Koyama, Nobuyuki; Nagase, Terumasa; Katsura, Yoshiya; Nakamura, Hiroyuki; Aoshiba, Kazutetsu
• Is Part Of: Clinical case reports. Volume 9:Issue 10(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-28
• Subjects: hypoglycemia -- insulin‐like growth factor II -- mesothelioma; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.5028
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Nonislet tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome characterized by refractory hypoglycemia, which often requires multifaceted therapy. We reported a case of a patient with pleural malignant mesothelioma and developed NICTH, for which chemotherapy, glucocorticoids, and nutrition were given to achieve optimal glycemic control. Abstract : In patients with tumors and hypoglycemia without clear etiology, nonislet cell tumor hypoglycemia (NICTH), which can cause severe refractory hypoglycemia, should be considered. If tumor resection is not feasible, a multifaceted therapeutic approach that includes anticancer drugs, corticosteroids, and nutrition may be required for the management of NICTH.